Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability
Francesca Bandinelli,1 Francesco Scazzariello,1 Emanuela Pimenta da Fonseca,2 Mittermayer Barreto Santiago,2 Claudio Marcassa,3 Francesca Nacci,1 Marco Matucci Cerinic1 1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; 2Service of Rheumatology, Hospital Sant...
Saved in:
Main Authors: | Bandinelli F (Author), Scazzariello F (Author), Pimenta da Fonseca E (Author), Barreto Santiago M (Author), Marcassa C (Author), Nacci F (Author), Matucci Cerinic M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of Axial Spondyloarthritis – Insights into Upadacitinib
by: Braun J, et al.
Published: (2022) -
Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman
by: G. Lopalco, et al.
Published: (2015) -
Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis
by: A. Spadaro, et al.
Published: (2013) -
Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis
by: Krasselt M, et al.
Published: (2016) -
Axial Spondyloarthritis: Patient-Reported Impact in Europe
by: Garrido-Cumbrera, Marco, et al.
Published: (2022)